Isolation, Purification and Characterization of L,D-transpeptidase 2 from Mycobacterium tuberculosis

S M Baldin1,2, T A Shcherbakova1, V K Švedas1

  • 1Lomonosov Moscow State University, Belozersky Institute of Physicochemical Biology, Leninskie gory 1, bldg. 40, 119991, Moscow, Russia.

Acta Naturae
|April 27, 2019
PubMed

Insights

Mycobacterium tuberculosis L,D-transpeptidase 2 is crucial for cell wall integrity and antibiotic resistance. This study optimized its purification and identified oxidation of Cys354 as a key inactivation factor.

Area of Science:

  • Biochemistry
  • Microbiology
  • Structural Biology

Background:

  • * *Mycobacterium tuberculosis* L,D-transpeptidase 2 is essential for synthesizing nonclassical 3-3 peptidoglycan cross-links.
  • * These cross-links confer resistance to penicillin antibiotics, posing a significant challenge in tuberculosis treatment.
  • * Understanding the enzyme's function and stability is critical for developing new anti-TB strategies.

Purpose of the Study:

  • * To optimize the cultivation, isolation, and purification of recombinant *M. tuberculosis* L,D-transpeptidase 2.
  • * To investigate the factors affecting enzyme stability, particularly the oxidation of its catalytic cysteine residue.
  • * To characterize the biochemical properties of the purified enzyme and a variant lacking domain A.

Main Methods:

  • * Optimization of recombinant protein expression and purification protocols.
  • * Biochemical assays to assess enzyme activity and stability.
  • * Determination of kinetic parameters for nitrocefin transformation.

Main Results:

  • * Optimized conditions for producing active recombinant L,D-transpeptidase 2.
  • * Identified oxidation of the free SH groups of catalytic cysteine Cys354 as a major cause of enzyme inactivation during expression and storage.
  • * Determined biochemical characteristics and kinetic constants for wild-type and domain A-lacking L,D-transpeptidase 2.

Conclusions:

  • * L,D-transpeptidase 2 is a viable target for anti-tuberculosis drug development.
  • * Preventing Cys354 oxidation is crucial for maintaining enzyme activity and stability.
  • * Further studies on domain A's role could reveal new therapeutic avenues.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
883
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
563
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.0K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
499
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H01:13

meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H

All meta-directing substituents are deactivating groups. These substituents withdraw electrons from the aromatic ring, making the ring less reactive toward electrophilic substitution. For example, the nitration of nitrobenzene is 100,000 times slower than that of benzene because of the deactivating effect of the nitro group. The first step in an electrophilic aromatic substitution is the addition of an electrophile to form a resonance-stabilized carbocation. The energy diagrams for...
6.6K